Literature DB >> 6229596

Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells.

S T Pals, H Gleichmann, E Gleichmann.   

Abstract

We studied the alloreactive properties of donor T cells obtained from F1 mice that had recovered from the allosuppression of acute graft-vs.-host disease (GVHD) and showed mild symptoms of chronic GVHD, i.e., so-called secondary chronic GVHD. To this end, we used (B10 x DBA/2)F1 mice that had been injected with 10(8) B10 spleen cells 100-150 d previously. Such GVHD F1 mice were repopulated by lympho-hematopoietic cells of donor (B10) origin, which exhibited split tolerance towards the host: Whereas F1-specific donor T helper (Th) cells as well as T cells proliferating in the mixed lymphocyte reaction were readily demonstrable, F1-specific T suppressor (Ts) and T killer (Tk) cells were not, or were hardly, detectable; responses against third-party alloantigens were normal. Upon adoptive transfer to nonirradiated secondary recipients, the B10 cells obtained from the repopulated GVH F1 mice induced F1-specific enlargement of the draining popliteal lymph node and enhancement of the IgG formation therein. B10 cells of the same kind were unable, however, to induce lethal GVHD upon transfer to 950 rad-irradiated secondary (B10 x DBA/2)F1 recipients. We conclude that alloactivated donor Ts/Tk cells disappear from the host at a relatively early stage of GVHD, i.e., at the end of acute GVHD , presumably because they are short-lived. By contrast, the longevity of alloactivated donor Th cells causes the symptoms of secondary chronic GVHD.

Entities:  

Mesh:

Year:  1984        PMID: 6229596      PMCID: PMC2187239          DOI: 10.1084/jem.159.2.508

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

Review 1.  Suppressive mechanisms involving sensitization and tolerance in contact allergy.

Authors:  H N Claman; S D Miller; M S Sy; J W Moorhead
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

2.  Immune function in fully allogeneic mouse bone marrow chimeras.

Authors:  S E Krown; R Coico; M P Scheid; G Fernandes; R A Good
Journal:  Clin Immunol Immunopathol       Date:  1981-05

3.  Models for the production of stable hematopoietic chimerism across major histocompatibility barriers in adults.

Authors:  T G Wegmann; J Rosovsky; G A Carlson; E Diener; D W Drell
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

4.  Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-vs-host disease.

Authors:  M S Tsoi; R Storb; S Dobbs; L Medill; E D Thomas
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

5.  Improvement of the protein A plaque assay for immunoglobulin secreting cells by using immunoglobulin-depleted guinea pig serum as a source of complement.

Authors:  A Van Oudenaren; H Hooijkaas; R Benner
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

6.  Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.

Authors:  E H Van Elven; A G Rolink; F V Veen; E Gleichmann
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

7.  Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse.

Authors:  F H Bach; M B Widmer; M L Bach; J Klein
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

8.  Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host disease.

Authors:  A G Rolink; T Radaszkiewicz; S T Pals; W G van der Meer; E Gleichmann
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

9.  Self recognition in allogeneic radiation bone marrow chimeras. A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells.

Authors:  A Singer; K S Hathcock; R J Hodes
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

10.  Diseases caused by reactions of T lymphocytes towards incompatible structures of the major histocompatibility complex. VI. Autoantibodies characteristic of systemic lupus erythematosus induced by abnormal T-B cell cooperation across I-E.

Authors:  F M van Rappard-van der Veen; A G Rolink; E Gleichmann
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  6 in total

1.  Nephrotic syndrome in a child after umbilical-cord-blood transplantation.

Authors:  Joo Hoon Lee; Bo Sang Kwon; Il Soo Ha; Hae Il Cheong; Kyung Chul Moon; Hyo Seop Ahn; Yong Choi
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

2.  Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease.

Authors:  L Rozendaal; S T Pals; E Gleichmann; C J Melief
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

3.  Completely allogeneic spleen cells induced cytolytic neonatal tolerance to alloantigens, but failed to establish allo-helper interactions with host T cells.

Authors:  A Ramos; M González; M López-Hoyos; R Carrió; J Merino
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

Review 4.  Bone marrow transplantation: the genetic and cellular basis of resistance to engraftment and acute graft-versus-host disease.

Authors:  J Ferrara; P Mauch; G Murphy; S J Burakoff
Journal:  Surv Immunol Res       Date:  1985

5.  Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes.

Authors:  D L Thiele; M L Eigenbrodt; S E Bryde; E H Eigenbrodt; P E Lipsky
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

6.  Regulation of autoimmunity and donor cell engraftment by recipient Lyt-2+ cells during the graft-versus-host reaction.

Authors:  S E Harper; J R Roubinian; W E Seaman
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.